五氟利多治疗急性精神病的对照试验。
Controlled trial of penfluridol in acute psychosis.
作者信息
van Praag H M, Schut T, Dols L, van Schilfgaarden R
出版信息
Br Med J. 1971 Dec 18;4(5789):710-3. doi: 10.1136/bmj.4.5789.710.
Abstract
A controlled study was made of penfluridol medication consisting of a single weekly oral dose of 30 mg in 30 patients with acute psychoses of varying type and origin. This medication was found to be effective. No significant side effects occurred.Several long-acting neuroleptics for injection are now available. The development of an oral compound of this type is an asset because of the manageability of the oral drug in the hands of family doctors and social psychiatrists.
摘要
对30例不同类型和病因的急性精神病患者进行了一项对照研究，给予每周一次口服30毫克五氟利多药物治疗。结果发现这种药物有效，且未出现明显副作用。目前有几种长效注射用抗精神病药物。开发这种口服复方制剂是一项优势，因为家庭医生和社会精神病医生便于使用口服药物。
相似文献
1
Controlled trial of penfluridol in acute psychosis.五氟利多治疗急性精神病的对照试验。
Br Med J. 1971 Dec 18;4(5789):710-3. doi: 10.1136/bmj.4.5789.710.
2
Safety evaluation of penfluridol, a new long-acting oral antipsychotic agent.新型长效口服抗精神病药物五氟利多的安全性评估
J Clin Pharmacol. 1974 Apr;14(4):202-9. doi: 10.1002/j.1552-4604.1974.tb01398.x.
3
[Long-acting neuroleptics. 3. Pilot study of penfluridol (R16341): psychometric data].[长效抗精神病药。3. 五氟利多（R16341）的初步研究：心理测量数据]
Acta Psychiatr Belg. 1972 Sep;72(5):595-601.
4
The use of an oral long-acting anti-psychotic agent, penfluridol, in schizophrenia.口服长效抗精神病药物五氟利多在精神分裂症中的应用。
Curr Med Res Opin. 1974;2(1):23-6. doi: 10.1185/03007997409111736.
5
[Clinical experiences with an oral, long-term neuroleptic agent: penfluridol].[一种口服长效抗精神病药物：五氟利多的临床经验]
Med Welt. 1973 Apr 13;24(15):600-3.
6
Penfluridol: a long-acting oral neuroleptic as therapeutic agent in chronic schizophrenia.五氟利多：一种长效口服抗精神病药，用作慢性精神分裂症的治疗药物。
Curr Ther Res Clin Exp. 1974 Oct;16(10):1041-58.
7
8
9
[Aspects of neuroleptic depot therapy with special consideration of clinical experiences with the preoral depot preparation Penfluridol (R 16 341-Jannsen)].
Int Pharmacopsychiatry. 1974;9(3):152-65.
10
[Initial results of clinical trial of a new long-acting neuroleptic agent: Fluspirelene].[一种新型长效抗精神病药物：氟螺利林的临床试验初步结果]
Minerva Med. 1971 Dec 26;62(98):4922-7.
引用本文的文献
1
Penfluridol synergizes with colistin to reverse colistin resistance in Gram-negative bacilli.五氟利多与黏菌素协同作用，逆转革兰氏阴性杆菌对黏菌素的耐药性。
Sci Rep. 2025 May 8;15(1):16114. doi: 10.1038/s41598-025-01303-9.
2
Structural analysis shows the mode of inhibition for Staphylococcus aureus lipase by antipsychotic penfluridol.结构分析显示了抗精神病药物五氟利多对金黄色葡萄球菌脂肪酶的抑制模式。
Sci Rep. 2025 Apr 14;15(1):11876. doi: 10.1038/s41598-025-94981-4.
3
Weekly Supervised Administration of Oral Antipsychotics: An Alternative to Long-Acting Injections?每周监督口服抗精神病药物治疗：长效注射的替代方案？
CNS Drugs. 2022 Apr;36(4):315-325. doi: 10.1007/s40263-022-00906-4. Epub 2022 Feb 28.
4
Penfluridol targets acid sphingomyelinase to inhibit TNF signaling and is therapeutic against inflammatory autoimmune diseases.苯氟雷司他通过靶向酸性鞘磷脂酶抑制 TNF 信号转导，对炎症性自身免疫性疾病具有治疗作用。
Arthritis Res Ther. 2022 Jan 19;24(1):27. doi: 10.1186/s13075-021-02713-6.
5
The Impact of Antipsychotic Formulations on Time to Medication Discontinuation in Patients with Schizophrenia: A Dutch Registry-Based Retrospective Cohort Study.抗精神病药物剂型对精神分裂症患者停药时间的影响：一项荷兰登记处基于回顾性队列研究。
CNS Drugs. 2021 Apr;35(4):451-460. doi: 10.1007/s40263-021-00802-3. Epub 2021 Apr 10.
6
Drug repurposing: Antimicrobial and antibiofilm effects of penfluridol against Enterococcus faecalis.药物重定位：奋乃静对粪肠球菌的抗菌和抗生物膜作用。
Microbiologyopen. 2021 Jan;10(1):e1148. doi: 10.1002/mbo3.1148. Epub 2020 Dec 20.
7
Drug rechanneling: A novel paradigm for cancer treatment.药物重定向：癌症治疗的新范例。
Semin Cancer Biol. 2021 Jan;68:279-290. doi: 10.1016/j.semcancer.2020.03.011. Epub 2020 May 11.
8
Chlorpromazine versus penfluridol for schizophrenia.氯丙嗪与五氟利多治疗精神分裂症的比较。
Cochrane Database Syst Rev. 2017 Sep 23;9(9):CD011831. doi: 10.1002/14651858.CD011831.pub2.
9
Penfluridol for schizophrenia.五氟利多治疗精神分裂症。
Cochrane Database Syst Rev. 2006 Apr 19;2006(2):CD002923. doi: 10.1002/14651858.CD002923.pub2.
10
Clinical use of psychotherapeutic drugs. I. Antipsychotic and antimanic drugs.精神治疗药物的临床应用。I. 抗精神病药和抗躁狂药。
Drugs. 1972;4(5):321-60. doi: 10.2165/00003495-197204050-00001.
本文引用的文献
1
A FOLLOW-UP OF SCHIZOPHRENIC PATIENTS IN EDINBURGH.爱丁堡精神分裂症患者的随访
Acta Psychiatr Scand. 1963;39(4):548-600. doi: 10.1111/j.1600-0447.1963.tb07482.x.
2
A simple and reliable subclassification of chronic schizophrenia.慢性精神分裂症的一种简单可靠的亚分类。
J Ment Sci. 1961 Sep;107:862-75. doi: 10.1192/bjp.107.450.862.
3
Relapse in chronic schizophrenics following abrupt withdrawal of tranquillizing medication.安定药物突然停药后慢性精神分裂症患者的复发情况。
Br J Psychiatry. 1969 Jun;115(523):679-86. doi: 10.1192/bjp.115.523.679.
4
The pharmacology of fluspirilene (R 6218), a potent, long-acting and injectable neuroleptic drug.
Arzneimittelforschung. 1970 Nov;20(11):1689-98.
5
[A long-acting neuroleptic. 3. Pilot study of penfluridol (R 16341)].[一种长效抗精神病药。3. 五氟利多（R 16341）的初步研究]
Acta Psychiatr Belg. 1970;70(4):523-51.
6
Maintenance therapy of chronic psychostic patients with a weekly oral dose of R 16 341. A controlled double-blind study.慢性精神病患者每周口服剂量R 16 341的维持治疗。一项对照双盲研究。
J Clin Pharmacol J New Drugs. 1970 Sep-Oct;10(5):330-41. doi: 10.1177/009127007001000507.
7
Dexbenzetimide in neuroleptic-induced parkinsonism. A double-blind crossover study with a 16-week follow-up.
J Clin Pharmacol J New Drugs. 1970 May-Jun;10(3):207-11.
Zotero 插件